HEPARIN BINDING TO THE UROKINASE KRINGLE DOMAIN

被引:89
作者
STEPHENS, RW
BOKMAN, AM
MYOHANEN, HT
REISBERG, T
TAPIOVAARA, H
PEDERSEN, N
GRONDAHLHANSEN, J
LLINAS, M
VAHERI, A
机构
[1] CARNEGIE MELLON UNIV, DEPT CHEM, PITTSBURGH, PA 15213 USA
[2] UNIV COPENHAGEN, INST MICROBIOL, DK-1353 COPENHAGEN, DENMARK
[3] TECH UNIV DENMARK, DEPT BIOCHEM & NUTR, DK-2800 LYNGBY, DENMARK
关键词
D O I
10.1021/bi00148a019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The binding of urokinase to immobilized heparin and dextran sulfate was studied using activity assays of the bound urokinase. The markedly higher binding observed with high M(r) urokinase compared to low M(r) urokinase indicated a role for the amino-terminal fragment (ATF). This was confirmed by the use of inactive truncated urokinase and monoclonal antibodies specific for the ATF in competition assays of urokinase binding. Antibody competition assays suggested a site in the kringle domain, and a synthetic decapeptide Arg-52-Trp-62 from the kringle sequence (kringle numbering convention) was competitive in assays of urokinase binding to dextran sulfate and heparin. Heparin binding to the urokinase kringle was unambiguously demonstrated via H-1 NMR spectroscopy at 500 MHz. Effective equilibrium association constants (K(a)*) were determined for the interaction of isolated kringle fragment and low M(r) heparin at pH 7.2. The binding was strong in salt-free (H2O)-H-2 (K(a)* approximately 57 mM-1) and remained significant in 0.15 M NaCl (K(a)* approximately 12 mM-1), supporting a potential physiological role for the interaction. This is the first demonstration of a function for the kringle domain of urokinase, and it suggests that while the classical kringle structure has specificity for lysine binding, there may also exist a class of kringles with affinity for polyanion binding.
引用
收藏
页码:7572 / 7579
页数:8
相关论文
共 55 条
[1]   INTERACTION OF HEPARIN WITH PLASMINOGEN ACTIVATORS AND PLASMINOGEN - EFFECTS ON THE ACTIVATION OF PLASMINOGEN [J].
ANDRADEGORDON, P ;
STRICKLAND, S .
BIOCHEMISTRY, 1986, 25 (14) :4033-4040
[2]  
BLASI F, 1988, Fibrinolysis, V2, P73, DOI 10.1016/0268-9499(88)90370-0
[3]   REVERSIBLE INDEPENDENT UNFOLDING OF THE DOMAINS OF UROKINASE MONITORED BY H-1-NMR [J].
BOGUSKY, MJ ;
DOBSON, CM ;
SMITH, RAG .
BIOCHEMISTRY, 1989, 28 (16) :6728-6735
[4]   H-1-NMR STRUCTURAL CHARACTERIZATION OF A RECOMBINANT KRINGLE-2 DOMAIN FROM HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR [J].
BYEON, IJL ;
KELLEY, RF ;
LLINAS, M .
BIOCHEMISTRY, 1989, 28 (24) :9350-9360
[5]   SOLUTION STRUCTURE OF THE TISSUE-TYPE PLASMINOGEN-ACTIVATOR KRINGLE-2 DOMAIN COMPLEXED TO 6-AMINOHEXANOIC ACID AN ANTIFIBRINOLYTIC DRUG [J].
BYEON, IJL ;
LLINAS, M .
JOURNAL OF MOLECULAR BIOLOGY, 1991, 222 (04) :1035-1051
[6]  
BYEON IJL, 1991, THESIS CARNEGIE MELL
[7]   MOLECULAR MODELING OF PROTEIN-GLYCOSAMINOGLYCAN INTERACTIONS [J].
CARDIN, AD ;
WEINTRAUB, HJR .
ARTERIOSCLEROSIS, 1989, 9 (01) :21-32
[8]   COMPARISON OF ESTERASE ACTIVITIES OF TRYPSIN PLASMIN AND THROMBIN ON GUANIDINOBENZOATE ESTERS . TITRATION OF ENZYMES [J].
CHASE, T ;
SHAW, E .
BIOCHEMISTRY, 1969, 8 (05) :2212-&
[9]   PLASMINOGEN ACTIVATORS, TISSUE DEGRADATION, AND CANCER [J].
DANO, K ;
ANDREASEN, PA ;
GRONDAHLHANSEN, J ;
KRISTENSEN, P ;
NIELSEN, LS ;
SKRIVER, L .
ADVANCES IN CANCER RESEARCH, 1985, 44 :139-266
[10]  
Dawson R.M.C., 1986, DATA BIOCH RES